Literature DB >> 2587969

[Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients].

R M Lüthy1, H J Kistler.   

Abstract

The occurrence of visceral leishmaniasis is rare in Switzerland. We discovered this disturbance in a patient while on immunosuppressive medication for mycosis fungoides. Untreated visceral leishmaniasis has a high mortality. It can be expected that more cases will be observed in patients treated with immunosuppressive drugs or in patients with the acquired immunodeficiency syndrome (AIDS).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587969

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  2 in total

1.  Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment.

Authors:  S Fenske; H J Stellbrink; H Albrecht; H Greten
Journal:  Klin Wochenschr       Date:  1991-10-31

2.  Infectivity of SARS-CoV-2: there Is Something More than D614G?

Authors:  Saathvik R Kannan; Austin N Spratt; Thomas P Quinn; Xiao Heng; Christian L Lorson; Anders Sönnerborg; Siddappa N Byrareddy; Kamal Singh
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.